default author photo

Luc Morris

Memorial Sloan Kettering Cancer Center - Department of Surgery

NY

United States

SCHOLARLY PAPERS

3

DOWNLOADS

165

TOTAL CITATIONS

2

Scholarly Papers (3)

1.

Pretreatment Neutrophil-to-Lymphocyte Ratio as a Predictor of Survival and Response to Therapy in Patients Treated with Immune Checkpoint Inhibitors

Number of pages: 37 Posted: 23 Jul 2020
Memorial Sloan Kettering Cancer Center - Department of Surgery, Memorial Sloan Kettering Cancer Center - Immunogenomics & Precision Oncology Platform (IPOP), Memorial Sloan Kettering Cancer Center - Immunogenomics & Precision Oncology Platform (IPOP), Memorial Sloan Kettering Cancer Center - Immunogenomics & Precision Oncology Platform (IPOP), Memorial Sloan Kettering Cancer Center - Information Systems, Memorial Sloan Kettering Cancer Center - Department of Surgery, Memorial Sloan Kettering Cancer Center - Department of Medicine, Memorial Sloan Kettering Cancer Center - Department of Surgery, Memorial Sloan Kettering Cancer Center - Department of Pathology, Memorial Sloan Kettering Cancer Center - Department of Medicine, Memorial Sloan Kettering Cancer Center - Department of Surgery, Memorial Sloan Kettering Cancer Center - Department of Medicine, Memorial Sloan Kettering Cancer Center - Department of Surgery, Memorial Sloan Kettering Cancer Center - Immunogenomics & Precision Oncology Platform (IPOP), Memorial Sloan Kettering Cancer Center - Department of Surgery, Memorial Sloan Kettering Cancer Center - Department of Surgery, Memorial Sloan Kettering Cancer Center - Department of Surgery, Memorial Sloan Kettering Cancer Center - Department of Surgery, Memorial Sloan Kettering Cancer Center - Department of Surgery, Memorial Sloan Kettering Cancer Center - Department of Surgery, Memorial Sloan Kettering Cancer Center - Department of Surgery, Memorial Sloan Kettering Cancer Center - Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center - Immunogenomics & Precision Oncology Platform (IPOP), Memorial Sloan Kettering Cancer Center - Immunogenomics & Precision Oncology Platform (IPOP), Memorial Sloan Kettering Cancer Center - Department of Pathology, Memorial Sloan Kettering Cancer Center - Department of Pathology, Memorial Sloan Kettering Cancer Center - Immunogenomics & Precision Oncology Platform (IPOP), Memorial Sloan Kettering Cancer Center - Department of Epidemiology and Biostatistics and Memorial Sloan Kettering Cancer Center - Department of Surgery
Downloads 67 (899,324)
Citation 1

Abstract:

Loading...

Immune Checkpoint Inhibitors; Immunotherapy; Neutrophil-to-Lymphocyte Ratio; Biomarkers

2.

Leveraging Big Data of Immune Checkpoint Blockade Response Identifies Novel Potential Targets

Number of pages: 45 Posted: 28 Jun 2021
Université de Montréal - Faculty of Pharmacy, University Health Network - Division of Medical Oncology and Hematology, University Health Network - Princess Margaret Bioinformatics and Computational Genomics Laboratory, University Health Network - Princess Margaret Bioinformatics and Computational Genomics Laboratory, University Health Network - Princess Margaret Bioinformatics and Computational Genomics Laboratory, University Health Network - Princess Margaret Bioinformatics and Computational Genomics Laboratory, University Health Network - Princess Margaret Bioinformatics and Computational Genomics Laboratory, Mount Sinai Hospital - Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center - Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center - Department of Surgery, Vall d’Hebron Institute of Oncology (VHIO), University Health Network - Princess Margaret Bioinformatics and Computational Genomics Laboratory and Université de Montréal - Faculty of Pharmacy
Downloads 66 (907,769)
Citation 1

Abstract:

Loading...

Immune Checkpoint Blockade, Immuno-Oncology Therapy, Cancer, Genomics, Meta-analysis, Machine Learning, Scientific Software

3.

Heterogeneity of PD-L1 expression between the primary tumor and matched lymph node metastases in head and neck squamous cell carcinomas

Number of pages: 28 Posted: 09 Oct 2025
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Memorial Sloan Kettering Cancer Center - Department of Surgery, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 32 (1,290,922)

Abstract:

Loading...

HNSCC, Immunotherapy, prognostic significance, survival, PD-L1 expression